621 Dupilumab in Adolescents With Moderate-To-Severe Atopic Dermatitis and a History of Inadequate Response, or Intolerance to Cyclosporine: Subgroup Analysis From a Pivotal 16-Week Trial
Journal of Investigative Dermatology - United Kingdom
doi 10.1016/j.jid.2019.03.697
Full Text
Open PDFAbstract
Available in full text
Date
May 1, 2019
Authors
Publisher
Elsevier BV